Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $38.5800 (-0.77%) ($38.2300 - $38.5800) on Tue. Sep. 27, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.33% (three month average) | RSI | 49 | Latest Price | $38.5800(-0.77%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.9% a day on average for past five trading days. | Weekly Trend | HALO declines -2.5% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(41%) IWM(34%) IWO(34%) IFRA(33%) IWN(33%) | Factors Impacting HALO price | HALO will decline at least -1.165% in a week (0% probabilities). VIXM(-11%) VXX(-6%) UUP(-5%) TBT(-5%) EDOC(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.165% (StdDev 2.33%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $33.1(-14.2%) | Resistance Level | $40.24 | 5 Day Moving Average | $38.88(-0.77%) | 10 Day Moving Average | $40.13(-3.86%) | 20 Day Moving Average | $40.24(-4.13%) | To recent high | -25.6% | To recent low | 0.2% | Market Cap | $5.273b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |